We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $24B
1-Year Est. Return 37.67%
This Fund
S&P 500
This Quarter Est. Return
+34.77%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
AUM
$1.54B
AUM Growth
-$138M
Cap. Flow
-$300M
Cap. Flow %
-19.47%
Top 10 Hldgs %
9.99%
Holding
2,498
New
653
Increased
404
Reduced
598
Closed
777

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$2.77M
2
CI icon
Cigna
CI
+$2.57M
3
META icon
Meta Platforms (Facebook)
META
+$2.48M
4
BIDU icon
Baidu
BIDU
+$2.2M
5
BHC icon
Bausch Health
BHC
+$2.09M

Sector Composition

Rank Sector Weight
1 Healthcare 4.98%
2 Technology 4.63%
3 Consumer Discretionary 3.8%
4 Industrials 1.77%
5 Financials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XRAY icon
601
CALL
Dentsply Sirona
XRAY
$2.63B
$594K 0.04%
10,500
-66,500
-86% -$3.71M
TREX icon
602
PUT
Trex
TREX
$4.56B
$593K 0.04%
13,200
+4,400
+50% +$194K
PFS icon
603
CALL
Provident Financial Services
PFS
$3.12B
$592K 0.04%
24,000
+12,000
+100% +$296K
VAL
604
CALL
DELISTED
Valaris plc Class A Ordinary Share
VAL
$590K 0.04%
89,900
+63,800
+244% +$311K
FRC
605
DELISTED
First Republic Bank
FRC
$588K 0.04%
+5,005
New +$541K
NOV icon
606
NOV
NOV
$7.47B
$586K 0.04%
23,377
-29,166
-56% -$656K
CTMX icon
607
CytomX Therapeutics
CTMX
$731M
$585K 0.04%
+70,397
New +$475K
PFPT
608
PUT
DELISTED
Proofpoint, Inc.
PFPT
$585K 0.04%
+5,100
New +$608K
EXAS
609
DELISTED
Exact Sciences
EXAS
$584K 0.04%
6,319
-2,917
-32% -$256K
SOHU
610
PUT
Sohu.com
SOHU
$345M
$582K 0.04%
52,100
+19,500
+60% +$204K
JOE icon
611
PUT
St. Joe Company
JOE
$3.53B
$581K 0.04%
+29,300
New +$543K
BBY icon
612
PUT
Best Buy
BBY
$18.6B
$579K 0.04%
6,600
-11,600
-64% -$888K
VG
613
CALL
DELISTED
Vonage Holdings Corporation
VG
$578K 0.04%
78,000
-104,400
-57% -$903K
CHWY icon
614
CALL
Chewy
CHWY
$8.99B
$577K 0.04%
19,900
-1,700
-8% -$43.5K
USB icon
615
PUT
US Bancorp
USB
$99.1B
$575K 0.04%
9,700
+3,900
+67% +$225K
MRTX
616
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$575K 0.04%
+4,462
New +$430K
SGI
617
Somnigroup International
SGI
$15.5B
$573K 0.04%
+26,328
New +$550K
DXCM icon
618
DexCom
DXCM
$28.3B
$569K 0.04%
+10,400
New +$493K
PAM icon
619
Pampa Energía
PAM
$4.62B
$567K 0.04%
+34,500
New +$524K
CLR
620
PUT
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$566K 0.04%
16,500
+12,900
+358% +$400K
PRNB
621
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$563K 0.04%
+10,280
New +$384K
PDCE
622
CALL
DELISTED
PDC Energy, Inc.
PDCE
$560K 0.04%
21,400
-1,100
-5% -$26.4K
ALGN icon
623
PUT
Align Technology
ALGN
$12.1B
$558K 0.04%
2,000
-600
-23% -$150K
FL
624
DELISTED
Foot Locker
FL
$557K 0.04%
14,274
-2,270
-14% -$95.6K
PVH icon
625
CALL
PVH
PVH
$3.83B
$557K 0.04%
5,300
-2,100
-28% -$200K

Similar funds

Walleye Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Walleye Capital held 2,498 positions worth $1.54B, down 8.2% from $1.68B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Walleye Capital withdrew a net $300M in Q4 2019, closing 777 positions and reducing 598 holdings. Its most notable exit was Cigna, an estimated $2.57M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 5% of assets, up from 1.9% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Walleye Capital opened a new position in Cypress Semiconductor worth $17M.

  • Walleye Capital's largest Q4 2019 buy was Cypress Semiconductor: 727,918 shares worth $17M.
  • Walleye Capital added most to Acacia Communications Inc in Q4 2019, an estimated $8.45M increase.
  • Walleye Capital's biggest Q4 2019 reduction was Humana, cutting an estimated $2.77M.
  • Walleye Capital fully exited Cigna in Q4 2019, selling an estimated $2.57M.
  • Walleye Capital's ten largest holdings make up 10% of its $1.54B portfolio in Q4 2019.
  • Walleye Capital opened 653 new positions and closed 777 in Q4 2019.
  • Walleye Capital's portfolio value fell 8.2% quarter-over-quarter to $1.54B.

Based on Walleye Capital's 13F filing for Q4 2019, filed 14 Feb 2020.